— Know what they know.
Not Investment Advice
Also trades as: PEARW (NASDAQ) · $vol 0M

PEAR NASDAQ

Pear Therapeutics, Inc.
1W: -43.2% 1M: -70.0% 3M: -99.5% 1Y: -99.9%
$0.03
Last traded 2023-05-23 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $4.1M mcap · 54M float · 18.53% daily turnover

Balance Sheet Trends

Total Assets
$95M -51.8% ▼
3Y CAGR: -4.6%
Total Liabilities
$65M -39.5% ▼
3Y CAGR: -28.4%
Shareholders Equity
$31M -66.2% ▼
Cash & Investments
$59M -66.0% ▼
3Y CAGR: -17.2%
Total Debt
$38M +39.3% ▲
3Y CAGR: +35.4%
Net Debt
-$11M +92.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$27M$111M$170M$48M
Short-Term Investments$77M$14M$5M$11M
Cash & ST Investments$104M$124M$175M$59M
Net Receivables$1M$257K$2M$7M
Inventory$0$0$0$69K
Other Current Assets$2M$1M$9M$7M
Total Current Assets$107M$126M$185M$73M
Property, Plant & Equip.$680K$4M$6M$15M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$2M$2M$6M$7M
Total Non-Current Assets$3M$6M$12M$22M
Total Assets$110M$132M$197M$95M
— Liabilities —
Accounts Payable$3M$5M$2M$3M
Short-Term Debt$4M$26M$27M$29M
Deferred Revenue$4M$267K$421K$284K
Other Current Liabilities$6M$10M$18M$16M
Total Current Liabilities$17M$41M$47M$49M
Long-Term Debt$11M$0$0$8M
Other Non-Current Liab.$526K$274M$60M$7M
Total Non-Current Liabilities$159M$274M$60M$15M
Total Liabilities$176M$315M$107M$65M
— Equity —
Common Stock$1K$1K$14K$14K
Retained Earnings-$70M-$183M-$248M-$323M
Accumulated OCI$29K$0-$1K-$47K
Total Stockholders Equity-$66M-$182M$90M$31M
Total Liabilities & Equity$110M$132M$197M$95M
— Key Metrics —
Total Debt$15M$26M$27M$38M
Net Debt-$12M-$85M-$143M-$11M
Total Investments$77M$14M$5M$11M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms